Literature DB >> 3044107

Steroid receptors, cellular kinetics, and lymph node status as prognostic factors in breast cancer.

S E Benner1, G M Clark, W L McGuire.   

Abstract

Steroid receptor status, cellular kinetics, abnormal proto-oncogene presence, and lymph node metastases all have been shown to provide prognostic information in breast cancer. The factors guide the choice of therapy and predict the course of the disease. Both disease-free survival and overall survival are predicted by these variables. Steroid receptors are the most reliable predictor of hormonal responsiveness. Lymph node involvement is crucial in determining the extent of the disease and the need for adjuvant therapy. Cellular kinetics and abnormal proto-oncogene presence predict tumor aggressiveness. Together these prognostic factors provide considerable information to the clinician.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3044107     DOI: 10.1097/00000441-198807000-00011

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  8 in total

Review 1.  AN OVERVIEW OF PROGNOSTIC MARKERS IN BREAST CANCER.

Authors:  G U Deshpande; Ramji Rai
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  Expression of estrogen receptor variant messenger RNAs and determination of estrogen receptor status in human breast cancer.

Authors:  A Huang; E R Leygue; L Snell; L C Murphy; P H Watson
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

3.  Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator.

Authors:  S Hayashi; K Hajiro-Nakanishi; Y Makino; H Eguchi; J Yodoi; H Tanaka
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

4.  Investigation of the origin of variant, truncated estrogen receptor-like mRNAs identified in some human breast cancer biopsy samples.

Authors:  L C Murphy; H Dotzlaw; J Hamerton; J Schwarz
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 5.  Integration of risk factors to allow patient selection for adjuvant systemic therapy in lymph node-negative breast cancer patients.

Authors:  W C Wood
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

6.  Genetic evolution of breast cancer: II. Relationship with estrogen and progesterone receptor expression.

Authors:  H Magdelenat; M Gerbault-Seureau; C Laine-Bidron; M Prieur; B Dutrillaux
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 7.  Oestrogen receptor: a stable phenotype in breast cancer.

Authors:  J F Robertson
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

8.  Coexpression of wild-type and variant oestrogen receptor mRNAs in a panel of human breast cancer cell lines.

Authors:  C G Castles; D M Klotz; S A Fuqua; S M Hill
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.